O’Melveny represented Viva Biotech on the listing Viva Biotech (1873.HK) executed its $194 million initial public offering and listing on the Main Board of the Hong…
Viva Biotech’s $194 Million Initial Public Offering
O’Melveny represented Viva Biotech on the listing Viva Biotech (1873.HK) executed its $194 million initial public offering and listing on the Main Board of the Hong…